Clover’s adjuvant choice for Covid-19 an edge, but comparison with IMV’s, Novavax’s vaccines limited

The shape of the spike protein in SARS-Cov-2 is essential to determining how to target the virus. Credit: Shutterstock



  • Clover Biopharmaceuticals